Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$515,067
+$203,685 QoQ
Shares Held
10,744
+26.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#706
of 1,348 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trek Financial, LLC holds $22,596,486 across 11 Drug Manufacturers - General names. NVO ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
39,151 | $9,943,179 | |
| 2 | LLY |
ELI LILLY & Co
|
3,679 | $4,412,703 | |
| 3 | AMGN |
Amgen Inc
|
7,005 | $2,536,650 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
16,440 | $2,077,029 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,583 | $1,102,915 | |
| 6 | ABBV |
AbbVie Inc.
|
3,156 | $794,175 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
10,744 | $515,067 | |
| 8 | NVS |
Novartis AG
|
2,210 | $346,351 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $515,067 | 10,744 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $311,382 | 8,473 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $351,479 | 6,908 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $311,687 | 5,617 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $295,198 | 4,277 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $211,953 | 2,464 | Shares | Sole | 2025-02-13 | |
| 2024-06-30 | $262,641 | 1,840 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||